000 | 01417 a2200421 4500 | ||
---|---|---|---|
005 | 20250515051412.0 | ||
264 | 0 | _c20070614 | |
008 | 200706s 0 0 eng d | ||
022 | _a1043-3074 | ||
024 | 7 |
_a10.1002/hed.20527 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpeleman, Luciƫnne | |
245 | 0 | 0 |
_aPrognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma. _h[electronic resource] |
260 |
_bHead & neck _cApr 2007 |
||
300 |
_a341-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xchemistry |
650 | 0 | 4 |
_aCathepsin D _xanalysis |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOropharyngeal Neoplasms _xchemistry |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xanalysis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xanalysis |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xanalysis |
700 | 1 | _aKerrebijn, Jeroen D F | |
700 | 1 | _aLook, Maxime P | |
700 | 1 | _aMeeuwis, Cees A | |
700 | 1 | _aFoekens, John A | |
700 | 1 | _aBerns, Els M J J | |
773 | 0 |
_tHead & neck _gvol. 29 _gno. 4 _gp. 341-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hed.20527 _zAvailable from publisher's website |
999 |
_c16732016 _d16732016 |